| 15:30 | Targeted Cancer Therapies (TCT): Classification and Overview | LLORENS BELLES V | ||
| 15:42 | Surface, Scleral, and Corneal Involvement in TCT | SAINZ DE LA MAZA M | ||
| 15:54 | Uveitis and Retinopathy Induced by MAPK/ERK Inhibitors | PICHI F | ||
| 16:06 | Uveitis Induced by Immune Checkpoint Inhibitors | MISEROCCHI E | ||
| 16:18 | Discussion and Q&A - All panel vs Audience | |||
| 16:30 | End of Session | |||